Four JAK Inhibitors Have Comparable Efficacy, Safety for RA
FRIDAY, Dec. 1, 2023 -- For patients with rheumatoid arthritis, the efficacy and safety of four Janus kinase (JAK) inhibitors is comparable, according to a study published online Nov. 1 in Rheumatology.
Shinya Hayashi, M.D., from the Kobe... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2023 Category: Pharmaceuticals Source Type: news
Ins and Outs of Rheumatoid Arthritis
In the webinar, Stanley B. Cohen, MD, broke down all things RA including what boosts your chances of having it, what risks come with RA, and more. (Source: WebMD Health)
Source: WebMD Health - December 1, 2023 Category: Consumer Health News Source Type: news
DMARDs Linked to Reduced Thyroid Disease Incidence DMARDs Linked to Reduced Thyroid Disease Incidence
In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 29, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Could Correcting Metabolic Dysfunction Treat Rheumatoid Arthritis?
(MedPage Today) -- Alterations in tryptophan metabolism are common among patients with rheumatoid arthritis (RA), researchers found, and preclinical studies suggest that correcting them is a viable treatment strategy.
Participants in France's... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 28, 2023 Category: Rheumatology Source Type: news
Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events
(MedPage Today) -- In contrast to recent data on tofacitinib (Xeljanz) in rheumatoid arthritis, patients with inflammatory bowel disease (IBD) who received biologic therapies appeared to have a lower risk for a major adverse cardiovascular event... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 28, 2023 Category: Gastroenterology Source Type: news
Picture quiz: Toenail presentations
The Nursing in Practice ‘picture quizzes’ aim to test your knowledge through photo presentations of symptoms. Work your way through them to understand the key clinical problems faced by patients, and how to correctly identify them. Press ‘start’ below to begin the quiz.
A 45-year-old woman is concerned about this black line that has appeared under her big toenail. Can you reassure her about the cause?
Fungal nail infection
Melanoma
Subungual haematoma
Ingrowing toenail
A 23-year-old woman wants to know what you are going to do about her ‘manky toenail’ as it is summer and she feels she ...
Source: Nursing in Practice - November 23, 2023 Category: Nursing Authors: Mollie Fraser-Andrews Tags: Dermatology Quiz toenail Source Type: news
How Viral Infections Cause Long-Term Health Problems
In a few patients, the immune system becomes misdirected, attacking the body instead of the virus. (Source: NYT Health)
Source: NYT Health - November 22, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Multiple Sclerosis Autoimmune Diseases Immune System Long Covid Chronic Fatigue Syndrome Antibodies Mononucleosis Rheumatoid Arthritis Bacteria Lupus Erythematosus Source Type: news
ACR: Higher BMI Linked to Worse Flare Symptoms in Early RA
TUESDAY, Nov. 21, 2023 -- For patients with early rheumatoid arthritis (RA), higher body mass index (BMI) is associated with worse flare symptoms, according to a study presented at the annual meeting of the American College of Rheumatology, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2023 Category: Pharmaceuticals Source Type: news
A commonly used arthritis medicine can cure baldness, shows a study
A recent study published in Indian Dermatology has found that tofacitinib, a drug commonly used for rheumatoid arthritis, has shown promising results in treating alopecia areata. The study revealed that 94.1% of the patients showed a complete or near-complete response to the medication. Additionally, 23.5% of the patients achieved complete hair growth within eight months of treatment. (Source: The Economic Times)
Source: The Economic Times - November 21, 2023 Category: Consumer Health News Source Type: news
Rheumatoid arthritis
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 21, 2023 Category: Consumer Health News Source Type: news
Novel Blood Test Can Detect Rheumatoid Arthritis Novel Blood Test Can Detect Rheumatoid Arthritis
An experimental assay detects epigenetic features within the unique patterns and sizes of cell-free DNA found in blood, but is it better than clinical diagnostics?MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 20, 2023 Category: Internal Medicine Tags: Rheumatology News Source Type: news
Treating Refractory Rheumatoid Arthritis Treating Refractory Rheumatoid Arthritis
The challenges of defining and treating refractory rheumatoid arthritis are discussed by Dr Philip Mease of Providence Swedish Medical Center and Dr Jon Giles of Columbia University Medical Center.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2023 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news
Uh-Oh, Is a Robot Coming for Your Radiographic Analysis Job?
(MedPage Today) -- SAN DIEGO -- Joint space narrowing (JSN) and erosions in rheumatoid arthritis (RA) were measured and graded about as well by computerized x-ray analysis as by a human rheumatologist, a researcher reported here.
With the live... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - November 15, 2023 Category: Radiology Source Type: news
Aclaris halts work on its experimental rheumatoid arthritis drug after clinical trial failure
Aclaris will discontinue further development of the drug candidate, including halting enrollment of its ongoing phase 2 trial targeting psoriatic arthritis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease
(MedPage Today) -- SAN DIEGO -- Rates of certain infections and other adverse effects were substantially higher in patients receiving sodium-glucose cotransporter-2 (SGLT-2) inhibitors when they also had rheumatoid arthritis or other systemic... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 14, 2023 Category: Cardiology Source Type: news
